Troponin T after endoscopic retrograde cholangiopancreatography: no evidence of harm.

2.50
Hdl Handle:
http://hdl.handle.net/10541/72655
Title:
Troponin T after endoscopic retrograde cholangiopancreatography: no evidence of harm.
Authors:
Martin, D F; Laasch, Hans-Ulrich; Kelly, A M; Hammonds, R; Wilbraham, L; Sastry, S; England, A
Abstract:
BACKGROUND AND STUDY AIMS: It is well recognized that myocardial ischemia can occur during endoscopic retrograde cholangiopancreatography (ERCP). Acute arrhythmias and ST segment changes have been reported by a number of authors, but the longer-term sequelae with regard to permanent myocardial damage are not known. The aim of this study was to determine the presence or absence of significant injury to the heart muscle. PATIENTS AND METHODS: Sixty-two patients undergoing therapeutic ERCP were assessed clinically and with electrocardiography (ECG) for the presence of ischemic heart disease before the procedure. Extensive intraprocedural monitoring was carried out, postprocedural ECGs were recorded, and serum troponin T levels were measured. The ECGs were evaluated blindly by a single cardiologist. RESULTS: In 61 of the 62 patients, no changes were observed between the ECGs before and after the procedure. One patient had postprocedural T wave inversion but a normal troponin T level, excluding myocardial damage. One patient with mild renal insufficiency and treated heart failure had borderline troponin T elevation (0.05 microg/l) but no ECG changes. No complications of ERCP occurred. CONCLUSIONS: Whilst ECG and rhythm changes indicating transient myocardial ischemia do occur during ERCP, there is no evidence that myocardial damage takes place as a consequence of this.
Affiliation:
Academic Deparment of Gastrointestinal Radiology, South Manchester University Hospitals, Manchester, United Kingdom. derrick.martin@smtr.nhs.uk
Citation:
Troponin T after endoscopic retrograde cholangiopancreatography: no evidence of harm. 2006, 38 (8):793-6 Endoscopy
Journal:
Endoscopy
Issue Date:
Aug-2006
URI:
http://hdl.handle.net/10541/72655
DOI:
10.1055/s-2006-944602
PubMed ID:
17001569
Type:
Article
Language:
en
ISSN:
0013-726X
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorMartin, D F-
dc.contributor.authorLaasch, Hans-Ulrich-
dc.contributor.authorKelly, A M-
dc.contributor.authorHammonds, R-
dc.contributor.authorWilbraham, L-
dc.contributor.authorSastry, S-
dc.contributor.authorEngland, A-
dc.date.accessioned2009-07-06T16:39:06Z-
dc.date.available2009-07-06T16:39:06Z-
dc.date.issued2006-08-
dc.identifier.citationTroponin T after endoscopic retrograde cholangiopancreatography: no evidence of harm. 2006, 38 (8):793-6 Endoscopyen
dc.identifier.issn0013-726X-
dc.identifier.pmid17001569-
dc.identifier.doi10.1055/s-2006-944602-
dc.identifier.urihttp://hdl.handle.net/10541/72655-
dc.description.abstractBACKGROUND AND STUDY AIMS: It is well recognized that myocardial ischemia can occur during endoscopic retrograde cholangiopancreatography (ERCP). Acute arrhythmias and ST segment changes have been reported by a number of authors, but the longer-term sequelae with regard to permanent myocardial damage are not known. The aim of this study was to determine the presence or absence of significant injury to the heart muscle. PATIENTS AND METHODS: Sixty-two patients undergoing therapeutic ERCP were assessed clinically and with electrocardiography (ECG) for the presence of ischemic heart disease before the procedure. Extensive intraprocedural monitoring was carried out, postprocedural ECGs were recorded, and serum troponin T levels were measured. The ECGs were evaluated blindly by a single cardiologist. RESULTS: In 61 of the 62 patients, no changes were observed between the ECGs before and after the procedure. One patient had postprocedural T wave inversion but a normal troponin T level, excluding myocardial damage. One patient with mild renal insufficiency and treated heart failure had borderline troponin T elevation (0.05 microg/l) but no ECG changes. No complications of ERCP occurred. CONCLUSIONS: Whilst ECG and rhythm changes indicating transient myocardial ischemia do occur during ERCP, there is no evidence that myocardial damage takes place as a consequence of this.en
dc.language.isoenen
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshBiological Markers-
dc.subject.meshCholangiopancreatography, Endoscopic Retrograde-
dc.subject.meshElectrocardiography-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshTroponin T-
dc.titleTroponin T after endoscopic retrograde cholangiopancreatography: no evidence of harm.en
dc.typeArticleen
dc.contributor.departmentAcademic Deparment of Gastrointestinal Radiology, South Manchester University Hospitals, Manchester, United Kingdom. derrick.martin@smtr.nhs.uken
dc.identifier.journalEndoscopyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.